Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
about
The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivoThe lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesTelodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells.Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cellsNew-generation platinum agents for solid tumors.Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells.Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin.Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer CellsLight-triggered CO delivery by a water-soluble and biocompatible manganese photoCORM.Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10.
P2860
Q34062814-FA7D70CF-A56A-4BCA-A3A2-36EA9D21138EQ34329204-C1E534F4-B289-4770-B331-C5E4E7ED39B3Q35032561-D6444E4C-5A53-43B7-B66A-C7D6819AC7E9Q35817322-B7DF8937-79BC-4F23-A0AC-7A51BB216E27Q37139330-DDE5DA33-4C34-416E-8FE4-C24D41742B2DQ37289000-3BE59E7D-0278-4235-A855-562E1C38A599Q37401326-DF53CE4D-072F-413F-B8D0-CFCACAB737B5Q39080724-0980A0A8-CFFF-4758-A90D-D4773E7BDD36Q39637660-5C4E9D2C-B709-4781-9581-259E3910A0EEQ39692780-695640A8-5A50-47FB-92A8-500BD3B25CCDQ41470356-2C8093B2-25F3-4878-9029-C2E3BFE10CBAQ46476730-2D95ACEB-50E5-40FF-AC1E-8D4063369ACEQ47100889-84E0F6A7-4CA2-4447-8407-DE217EE39470
P2860
Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Platinum(IV) complex with adam ...... latin in ovarian cancer cells.
@en
type
label
Platinum(IV) complex with adam ...... latin in ovarian cancer cells.
@en
prefLabel
Platinum(IV) complex with adam ...... latin in ovarian cancer cells.
@en
P2093
P1433
P1476
Platinum(IV) complex with adam ...... platin in ovarian cancer cells
@en
P2093
Ales Kroutil
Alois Kozubík
Jirina Hofmanová
Karel Soucek
Olga Blanárová
Viktor Horváth
P356
10.1016/J.YGYNO.2005.11.016
P407
P577
2005-12-20T00:00:00Z